Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Thresher

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Regulatory Toxicology and Pharmacology : RTP|February 8, 2021
Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosaminesRobert Thomas, Andrew Thresher, David J Ponting
Toxicology Research|October 8, 2019
Generation of TD<sub>50</sub> values for carcinogenicity study dataAndrew Thresher, John Paul Gosling, Richard Williams
Regulatory Toxicology and Pharmacology : RTP|July 26, 2023
A deep dive into historical Ames study data for N-nitrosamine compoundsRachael E Tennant, David J Ponting, Andrew Thresher
Toxicology Letters|November 3, 2023
Use of the TD50 99 % CI for single dose rodent carcinogenicity studiesRobert Thomas, Antonio Anax F Oliveira, David J Ponting, et al.
Archives of Toxicology|January 3, 2025
Critical comparison of BMD and TD<sub>50</sub> methods for the calculation of acceptable intakes for N-nitroso compoundsRobert Thomas, David J Ponting, Andrew Thresher, et al.
Regulatory Toxicology and Pharmacology : RTP|August 11, 2020
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataAndrew Thresher, Robert Foster, David J Ponting, et al.
Toxicology Mechanisms and Methods|January 5, 2023
Enhancing global and local decision making for chemical safety assessments through increasing the availability of dataAdrian Fowkes, Robert Foster, Steven Kane, et al.
Regulatory Toxicology and Pharmacology : RTP|June 24, 2026
Which Carcinogenicity Study Should I use? Automated Identification of Reliable StudiesAndrew Thresher, Jessica E Halliday, Grace Kocks, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|September 28, 2020
The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7Robert S Foster, Adrian Fowkes, Alex Cayley, et al.
Regulatory Toxicology and Pharmacology : RTP|August 23, 2022
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosaminesAlejandra Trejo-Martin, Joel P Bercu, Andrew Thresher, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Regulatory Toxicology and Pharmacology : RTP|February 8, 2021
Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosaminesRobert Thomas, Andrew Thresher, David J Ponting
Toxicology Research|October 8, 2019
Generation of TD<sub>50</sub> values for carcinogenicity study dataAndrew Thresher, John Paul Gosling, Richard Williams
Regulatory Toxicology and Pharmacology : RTP|July 26, 2023
A deep dive into historical Ames study data for N-nitrosamine compoundsRachael E Tennant, David J Ponting, Andrew Thresher
Toxicology Letters|November 3, 2023
Use of the TD50 99 % CI for single dose rodent carcinogenicity studiesRobert Thomas, Antonio Anax F Oliveira, David J Ponting, et al.
Archives of Toxicology|January 3, 2025
Critical comparison of BMD and TD<sub>50</sub> methods for the calculation of acceptable intakes for N-nitroso compoundsRobert Thomas, David J Ponting, Andrew Thresher, et al.
Regulatory Toxicology and Pharmacology : RTP|August 11, 2020
Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity dataAndrew Thresher, Robert Foster, David J Ponting, et al.
Toxicology Mechanisms and Methods|January 5, 2023
Enhancing global and local decision making for chemical safety assessments through increasing the availability of dataAdrian Fowkes, Robert Foster, Steven Kane, et al.
Regulatory Toxicology and Pharmacology : RTP|June 24, 2026
Which Carcinogenicity Study Should I use? Automated Identification of Reliable StudiesAndrew Thresher, Jessica E Halliday, Grace Kocks, et al.
Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society|September 28, 2020
The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7Robert S Foster, Adrian Fowkes, Alex Cayley, et al.
Regulatory Toxicology and Pharmacology : RTP|August 23, 2022
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosaminesAlejandra Trejo-Martin, Joel P Bercu, Andrew Thresher, et al.
Pageof 1